Implementation of a 1021-gene liquid biopsy assay for real-world tumor genomic profiling in oncology practice
Chrysiida Florou-Chatzigiannidou, Eirini Papadopoulou, Vasiliki Metaxa-Mariatou, Aikaterini Tsantikidi et autres
The application of advanced next-generation sequencing (NGS) technologies in the analysis of circulating tumor DNA (ctDNA) enabled the comprehensive evaluation of tumor-derived alterations in the bloodstream. In this study, we evaluated the analytical performance and clinical utility of a large-scale liquid biopsy …
gr, ro, tr, gb, lb (code pays fourni par la source)